Error message

The page you requested does not exist. For your convenience, a search was performed using the query news events news 2016 03 14.

Page not found

You are here

Lisa Szymecko, JD, PhD

Alumni

Lisa Szymecko joined CBSSM in May 2012 as a Research Area Specialist Intermediate, working as the study coordinator for Susan Goold on the DECIDERS and PCORI projects.


Lisa earned her Bachelors of Science degree in Chemical Engineering from Michigan Technological University, her Juris Doctorate from Detroit College of Law, and her PhD in Resource Development from Michigan State University.

Last Name: 
Syzmecko
Fri, October 27, 2017

An older Behavioral Economics study by Brian Zikmund-Fisher and Andrew Parker was recently highlighted in a Nerdwallet Blog about the continued demand for rent-to-own contracts.

Research Topics: 
Mon, March 19, 2018

The new American Society for Radiation Oncology (ASTRO) guideline for treating breast cancer patients with whole breast irradiation recommends that most patients receive an accelerated treatment, known as hypofractioned therapy, instead of the conventional one. Reshma Jagsi is co-chair of task force that compiled the guideline.

Funded by: NIH

Funding Years: 2016-2021

 

There is a fundamental gap in understanding how Mild Cognitive Impairment (MCI) influences treatment and Decision Making for serious illnesses, like Cardiovascular disease (CVD), in older patients. Poor understanding of Clinical Decision Making is a critical barrier to the design of interventions to improve the quality and outcomes of CVD care of in older patients with MCI. The long-term goal of this research is to develop, test, and disseminate interventions aimed to improve the quality and outcomes of CVD care and to reduce CVD-related disability in older Americans with MCI. The objective of this application is to determine the extent to which people with MCI are receiving sub-standard care for the two most common CVD events, Acute myocardial infarction (AMI) and acute ischemic stroke, increasing the chance of mortality and morbidity in a population with otherwise good quality of life, and to determine how MCI influences patient preferences and physician recommendations for treatment. AMI and acute ischemic stroke are excellent models of serious, acute illnesses with a wide range of effective therapies for acute management, Rehabilitation, and secondary prevention. Our central hypothesis is that older Adults with MCI are undertreated for CVD because patients and physicians overestimate their risk of dementia and underestimate their risk of CVD. This hypothesis has been formulated on the basis of preliminary data from the applicants' pilot research. The rationale for the proposed research is that understanding how patient preferences and physician recommendations contribute to underuse of CVD treatments in patients with MCI has the potential to translate into targeted interventions aimed to improve the quality and outcomes of care, resulting in new and innovative approaches to the treatment of CVD and other serious, acute illnesses in Adults with MCI. Guided by strong preliminary data, this hypothesis will be tested by pursuing two specific aims: 1) Compare AMI and stroke treatments between MCI patients and cognitively normal patients and explore differences in Clinical outcomes associated with treatment differences; and 2) Determine the influence of MCI on patient and surrogate preferences and physician recommendations for AMI and stroke treatment. Under the first aim, a health services research approach- shown to be feasible in the applicants' hands-will be used to quantify the extent and outcomes of treatment differences for AMI and acute ischemic stroke in older patients with MCI. Under the second aim, a multi-center, mixed-methods approach and a national physician survey, which also has been proven as feasible in the applicants' hands, will be used to determine the influence of MCI on patient preferences and physician recommendations for AMI and stroke treatment. This research proposal is innovative because it represents a new and substantially different way of addressing the important public health problem of enhancing the health of older Adults by determining the extent and causes of underuse of effective CVD treatments in those with MCI. The proposed research is significant because it is expected to vertically advance and expand understanding of how MCI influences treatment and Decision Making for AMI and ischemic stroke in older patients. Ultimately, such knowledge has the potential to inform the development of targeted interventions that will help to improve the quality and outcomes of CVD care and to reduce CVD-related disability in older Americans.

PI: Deborah Levine

CO(s): Darin Zahuranec, MD & Ken Lenga, MD. PhD.

Thu, December 20, 2007

A CBSSM study found that colostomy patients who felt that their condition was irreversible reported better quality of life than those who hoped that they would be cured. For a summary, see this press release and video. The researchers are Dylan M. Smith, PhD; Peter A. Ubel, MD; Aleksandra Jankovic, MS (all at the University of Michigan); and George Loewenstein, PhD, (of Carnegie Mellon University). Health Psychology will publish the article in mid-November 2009.

Press coverage of this research has been extensive. Peter Bregman reported on the study in the July 2009 Business Week Online, applying the concepts to help people manage their stressful and unpredictable lives. Read his full article here. Preliminary data from this study were cited in the 7th Annual “Year in Ideas” issue of the New York Times Magazine in December 2007. Read recent international media coverage:
US News and World Report Health Day
Voice of America Radio
Daily Mail UK
Reuters India

CBSSM Seminar: Aaron Scherer, PhD

Wed, February 03, 2016, 3:00pm to 4:00pm
Location: 
NCRC, Building 16, Room 266C

Aaron Scherer, PhD


CBSSM Postdoctoral Fellow

The Language of Medicine

Is the way we talk about health and medicine simply expressive or does the language we use actually change how we perceive and respond to health risks and medical interventions? Aaron Scherer will discuss a number of studies that explore how metaphors, labels, and explanations may shape our health-related perceptions and behavior.

CBSSM Seminar: Michael D. Fetters, MD, MPH, MA

Thu, April 14, 2016, 3:00pm to 4:00pm
Location: 
NCRC Building 16, Conference Rm 266C

Michael D. Fetters, M.D., M.P.H., M.A.
Professor, University of Michigan
Co-Director, Michigan Mixed Methods Research and Scholarship Program
Director, Japanese Family Health Program
Co-Editor, Journal of Mixed Methods Research

"Mixed methods research approaches for empirical medical ethics”

Abstract: Mixed methods research involves the integration of qualitative and quantitative methodology. The purpose of this presentation is to illustrate potential applications of mixed methods methodology for conducting empirical medical ethics research.

Thu, July 14, 2016

A new article in The Conversation authored by CBSSM Co-Director Raymond De Vries and colleague Tom Tomlinson from Michigan State University explores ethical concerns that may arise when patients donate blood and tissue samples to biobanks.

The article highlights results from their national survey, which indicated that respondents were not solely concerned with privacy, but had moral concerns about how their donations could be used in future research.

The novelty of risk and vaccination intentions (May-12)

It's 2009.  Early in the year, a 9-year-old girl from California became the first person with a confirmed case of H1N1 ("swine") influenza in the United States.  Shortly thereafter, the U.S. declared a public health emergency and the World Health Organization declared a phase 6 pandemic (the highest level possible).  By September 2009 a vaccination was developed and was available within a month.

You've been following the news about the H1N1 influenza as developments have unfolded throughout the year, and you feel some concern.  You have been wondering about the risk of coming down with the H1N1 flu yourself and have been thinking about whether you should be vaccinated. 

Pages